Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze ELVN stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ELVN investment potential.

What is ELVN stock price today?

Get real-time ELVN stock price, historical data, and price charts on Financhill. Track ELVN performance with our advanced analysis tools.

Is ELVN a good investment?

Evaluate ELVN investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ELVN stock?

To buy ELVN stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ELVN?

View detailed market capitalization data and company valuation metrics for ELVN on our comprehensive analysis page.

What is the P/E ratio of ELVN?

Use our fundamental analysis tools to view ELVN P/E ratio and compare valuation metrics with industry peers.

What are ELVN earnings?

View ELVN earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Enliven Therapeutics, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

ELVN
Enliven Therapeutics, Inc.

Last Price:

$43.19

Seasonality Move:

9.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Enliven Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Enliven Therapeutics, Inc. has on average historically risen by 25.9% based on the past 6 years of stock performance.
Enliven Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Enliven Therapeutics, Inc. Stock Undervalued?

The current Enliven Therapeutics, Inc. [ELVN] share price is $43.16. The Score for ELVN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
ELVN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Enliven Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Enliven Therapeutics, Inc. has on average historically risen by 25.9% based on the past 6 years of stock performance.

Enliven Therapeutics, Inc. Stock Rating

Sell

Enliven Therapeutics, Inc. (ELVN) is a Sell

Is Enliven Therapeutics, Inc. overpriced?

Enliven Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Enliven Therapeutics, Inc. Stock Price History

Is ELVN stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ELVN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

enliventherapeutics.com

52-Week Data

52-Week High:

43.35

52-Week Low:

13.30

Prediction Charts

Market Cap:

2.9B

Price in USD:

43.16

Volume:

3.1M

Beta:

0.78

Technical Analysis

SMA50:

30.05

SMA100:

25.26

SMA200:

22.80

52-Wk Change:

141.52%

Stock Predictions

Is Enliven Therapeutics, Inc. stock public?

Yes, Enliven Therapeutics, Inc. is a publicly traded company.
What is the Enliven Therapeutics, Inc. stock quote today?

The Enliven Therapeutics, Inc. stock price is 43.16 USD today.
How to buy Enliven Therapeutics, Inc. stock online?

You can buy Enliven Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Mar-18	27.79	27.25	28.04	26.70
Mar-19	27.10	30.05	31.76	26.72
Mar-20	30.22	29.03	30.34	28.62
Mar-23	29.22	30.81	31.35	28.96
Mar-24	30.88	31.15	31.32	29.37
Mar-25	33.76	35.53	36.73	33.76
Mar-26	35.66	39.29	40.62	35.64
Mar-27	39.29	38.83	39.59	37.72
Mar-30	38.29	36.59	39.22	35.60
Mar-31	36.52	39.20	39.35	36.43
Apr-1	39.15	37.79	40.00	37.56
Apr-2	37.07	38.83	38.88	36.96
Apr-6	38.74	38.94	40.42	38.74
Apr-7	38.76	43.16	43.35	38.76

Enliven Therapeutics, Inc. Earnings

Enliven Therapeutics, Inc. Earnings Report: Per Share Enliven Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Enliven Therapeutics, Inc. Forecast Revenue Growth

Enliven Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Enliven Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.60 per share.

* Enliven Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.